135 related articles for article (PubMed ID: 1654240)
21. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial.
Sherman KE; Sjogren M; Creager RL; Damiano MA; Freeman S; Lewey S; Davis D; Root S; Weber FL; Ishak KG; Goodman ZD
Hepatology; 1998 Apr; 27(4):1128-35. PubMed ID: 9537454
[TBL] [Abstract][Full Text] [Related]
22. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
Ferenci P; Stauber R; Propst A; Fiedler R; Müller C; Gschwantler M; Schütze K; Datz C; Judmaier G; Vogel W; Krejs GJ; Gangl A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):103S-108S. PubMed ID: 9011466
[TBL] [Abstract][Full Text] [Related]
23. Treatment of HCV liver disease by recombinant interferon alpha.
Bailly F; Si N; Si A; Trepo C
Nephrol Dial Transplant; 1996; 11 Suppl 4():56-7. PubMed ID: 8918757
[TBL] [Abstract][Full Text] [Related]
24. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
[TBL] [Abstract][Full Text] [Related]
25. High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial.
Sáez-Royuela F; Porres JC; Moreno A; Castillo I; Martinez G; Galiana F; Carreño V
Hepatology; 1991 Feb; 13(2):327-31. PubMed ID: 1899852
[TBL] [Abstract][Full Text] [Related]
26. Pilot study of recombinant human alpha-interferon for chronic non-A, non-B hepatitis.
Kakumu S; Arao M; Yoshioka K; Ichimiya H; Murase K; Aoi T; Kusakabe A
Am J Gastroenterol; 1989 Jan; 84(1):40-5. PubMed ID: 2521421
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trial.
Realdi G; Diodati G; Bonetti P; Scaccabarozzi S; Alberti A; Ruol A
J Hepatol; 1990; 11 Suppl 1():S68-71. PubMed ID: 2127791
[TBL] [Abstract][Full Text] [Related]
28. Treatment of chronic hepatitis C with recombinant human interferon-alpha 2a: results of a randomized controlled clinical trial.
Diodati G; Bonetti P; Noventa F; Casarin C; Rugge M; Scaccabarozzi S; Tagger A; Pollice L; Tremolada F; Davite C
Hepatology; 1994 Jan; 19(1):1-5. PubMed ID: 7506223
[TBL] [Abstract][Full Text] [Related]
29. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
[TBL] [Abstract][Full Text] [Related]
30. Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.
Jacyna MR; Brooks MG; Loke RH; Main J; Murray-Lyon IM; Thomas HC
BMJ; 1989 Jan; 298(6666):80-2. PubMed ID: 2493302
[TBL] [Abstract][Full Text] [Related]
31. Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon.
Oliveri F; Santantonio T; Bellati G; Colombatto P; Mels GC; Carriero L; Dastoli G; Pastore G; Ideo G; Bonino F; Brunetto MR
Am J Gastroenterol; 1999 May; 94(5):1366-72. PubMed ID: 10235220
[TBL] [Abstract][Full Text] [Related]
32. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks.
Reichard O; Foberg U; Frydén A; Mattsson L; Norkrans G; Sönnerborg A; Wejstål R; Yun ZB; Weiland O
Hepatology; 1994 Feb; 19(2):280-5. PubMed ID: 7507462
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, controlled trial of consensus interferon in the treatment of Chinese patients with chronic hepatitis C.
Hwang SJ; Lee SD; Chan CY; Lu RH; Chang FY
Am J Gastroenterol; 1999 Sep; 94(9):2496-500. PubMed ID: 10484014
[TBL] [Abstract][Full Text] [Related]
34. A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies.
Schvarcz R; Weiland O; Wejstål R; Norkrans G; Frydén A; Foberg U
Scand J Infect Dis; 1989; 21(6):617-25. PubMed ID: 2482536
[TBL] [Abstract][Full Text] [Related]
35. Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study.
Villa E; Trande P; Grottola A; Buttafoco P; Rebecchi AM; Stroffolini T; Callea F; Merighi A; Camellini L; Zoboli P; Cosenza R; Miglioli L; Loria P; Iori R; Carulli N; Manenti F
Dig Dis Sci; 1996 Jun; 41(6):1241-7. PubMed ID: 8654159
[TBL] [Abstract][Full Text] [Related]
36. Re-treatment of interferon-resistant patients with chronic hepatitis C with interferon-alpha.
Bresci G; Parisi G; Banti S; Capzia A
J Viral Hepat; 1995; 2(3):155-8. PubMed ID: 7493311
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France.
Marcellin P; Boyer N; Giostra E; Degott C; Courouce AM; Degos F; Coppere H; Cales P; Couzigou P; Benhamou JP
Hepatology; 1991 Mar; 13(3):393-7. PubMed ID: 1900254
[TBL] [Abstract][Full Text] [Related]
38. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
39. A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis.
Saracco G; Rosina F; Torrani Cerenzia MR; Lattore V; Chiandussi L; Gallo V; Petrino R; De Micheli AG; Donegani E; Solinas A
J Hepatol; 1990; 11 Suppl 1():S43-9. PubMed ID: 2127787
[TBL] [Abstract][Full Text] [Related]
40. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
Lindsay KL; Davis GL; Schiff ER; Bodenheimer HC; Balart LA; Dienstag JL; Perrillo RP; Tamburro CH; Goff JS; Everson GT; Silva M; Katkov WN; Goodman Z; Lau JY; Maertens G; Gogate J; Sanghvi B; Albrecht J
Hepatology; 1996 Nov; 24(5):1034-40. PubMed ID: 8903371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
